Guardian Capital Advisors (Canada)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,572
| Closed | -$210K | – | 166 |
|
|
2023
Q1 | $210K | Sell |
5,572
-1,480
| -21% | -$51.8K | 0.02% | 142 |
|
|
2022
Q4 | $248K | Sell |
7,052
-12,296
| -64% | -$410K | 0.03% | 145 |
|
|
2022
Q3 | $588K | Sell |
19,348
-8,776
| -31% | -$333K | 0.07% | 108 |
|
|
2022
Q2 | $1.41M | Hold |
28,124
| – | – | 0.16% | 83 |
|
|
2022
Q1 | $1.64M | Sell |
28,124
-4,020
| -13% | -$218K | 0.16% | 88 |
|
|
2021
Q4 | $1.82M | Sell |
32,144
-1,720
| -5% | -$89.5K | 0.18% | 84 |
|
|
2021
Q3 | $1.63M | Sell |
33,864
-5,326
| -14% | -$268K | 0.17% | 82 |
|
|
2021
Q2 | $1.98M | Sell |
39,190
-9,128
| -19% | -$439K | 0.2% | 80 |
|
|
2021
Q1 | $2.18M | Sell |
48,318
-1,000
| -2% | -$45.4K | 0.25% | 73 |
|
|
2020
Q4 | $2.32M | Sell |
49,318
-924
| -2% | -$42.4K | 0.31% | 74 |
|
|
2020
Q3 | $2.34M | Sell |
50,242
-1,908
| -4% | -$95.6K | 0.36% | 68 |
|
|
2020
Q2 | $1.92M | Buy |
52,150
+524
| +1% | +$26.9K | 0.37% | 67 |
|
|
2020
Q1 | $1.69M | Sell |
51,626
-628
| -1% | -$33.5K | 0.41% | 60 |
|
|
2019
Q4 | $3.07M | Sell |
52,254
-1,636
| -3% | -$91K | 0.39% | 62 |
|
|
2019
Q3 | $2.77M | Sell |
53,890
-868
| -2% | -$44.7K | 0.37% | 62 |
|
|
2019
Q2 | $2.83M | Sell |
54,758
-248
| -0.5% | -$12.4K | 0.37% | 61 |
|
|
2019
Q1 | $2.74M | Sell |
55,006
-2,360
| -4% | -$118K | 0.37% | 63 |
|
|
2018
Q4 | $2.77M | Sell |
57,366
-652
| -1% | -$32.1K | 0.4% | 60 |
|
|
2018
Q3 | $2.86M | Sell |
58,018
-5,060
| -8% | -$257K | 0.39% | 64 |
|
|
2018
Q2 | $3.25M | Sell |
63,078
-3,416
| -5% | -$172K | 0.44% | 61 |
|
|
2018
Q1 | $3.37M | Sell |
66,494
-14,908
| -18% | -$694K | 0.47% | 60 |
|
|
2017
Q4 | $3.89M | Sell |
81,402
-13,538
| -14% | -$625K | 0.51% | 53 |
|
|
2017
Q3 | $4.85M | Buy |
94,940
+2,664
| +3% | +$135K | 0.67% | 46 |
|
|
2017
Q2 | $4.9M | Buy |
92,276
+992
| +1% | +$52.9K | 0.7% | 44 |
|
|
2017
Q1 | $4.73M | Buy |
91,284
+6,628
| +8% | +$336K | 0.67% | 45 |
|
|
2016
Q4 | $4.2M | Buy |
84,656
+8,410
| +11% | +$415K | 0.61% | 49 |
|
|
2016
Q3 | $4.06M | Sell |
76,246
-892
| -1% | -$48.9K | 0.73% | 45 |
|
|
2016
Q2 | $4.15M | Sell |
77,138
-3,776
| -5% | -$199K | 0.77% | 44 |
|
|
2016
Q1 | $4.21M | Sell |
80,914
-624
| -0.8% | -$31.1K | 0.78% | 42 |
|
|
2015
Q4 | $4.11M | Buy |
81,538
+4,312
| +6% | +$220K | 0.85% | 42 |
|
|
2015
Q3 | $3.72M | Sell |
77,226
-1,796
| -2% | -$93.5K | 0.77% | 44 |
|
|
2015
Q2 | $4.32M | Buy |
79,022
+2,776
| +4% | +$156K | 0.81% | 45 |
|
|
2015
Q1 | $5.5M | Buy |
76,246
+1,888
| +3% | +$108K | 0.83% | 45 |
|
|
2014
Q4 | $4.71M | Buy |
74,358
+7,748
| +12% | +$433K | 0.77% | 46 |
|
|
2014
Q3 | $4.25M | Buy |
66,610
+6,692
| +11% | +$410K | 0.71% | 51 |
|
|
2014
Q2 | $4.03M | Buy |
59,918
+1,284
| +2% | +$86.9K | 0.7% | 50 |
|
|
2014
Q1 | $3.83M | Buy |
58,634
+368
| +0.6% | +$24.9K | 0.73% | 49 |
|
|
2013
Q4 | $3.96M | Buy |
58,266
+2,300
| +4% | +$149K | 0.78% | 44 |
|
|
2013
Q3 | $3.52M | Buy |
55,966
+1,880
| +3% | +$121K | 0.75% | 45 |
|
|
2013
Q2 | $3.4M | Buy |
+54,086
| New | +$3.43M | 0.96% | 38 |
|
Other funds holding GSK
JEST
